Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia

Anne Weissbach; Annika Steinmeier; Martje G. Pauly; Duha M. Al-Shorafat; Gerard Saranza; Anthony E. Lang; Norbert Brüggemann; Vera Tadic; Christine Klein; Katja Lohmann; Matt J.N. Brown; Christian Beste; Alexander Münchau; Tobias Bäumer

doi:10.1002/mds.28679

Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia

Anne Weissbach^*, Annika Steinmeier, Martje G. Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony E. Lang, Norbert Brüggemann, Vera Tadic, Christine Klein, Katja Lohmann, Matt J.N. Brown, Christian Beste, Alexander Münchau, Tobias Bäumer

^*Corresponding author for this work

Original language	English
Journal	Movement Disorders
ISSN	0885-3185
DOIs	https://doi.org/10.1002/mds.28679
Publication status	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/mds.28679

Cite this

@article{0fa9d173b1b64825bb96a3dbccaffcb9,

title = "Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia",

author = "Anne Weissbach and Annika Steinmeier and Pauly, {Martje G.} and Al-Shorafat, {Duha M.} and Gerard Saranza and Lang, {Anthony E.} and Norbert Br{\"u}ggemann and Vera Tadic and Christine Klein and Katja Lohmann and Brown, {Matt J.N.} and Christian Beste and Alexander M{\"u}nchau and Tobias B{\"a}umer",

note = "Funding Information: A.W. reports the following: Else Kr{\"o}ner‐Fresenius grant (EKFS, 2018_A55), German Research Foundation (DFG, WE5919/2–1), and Edmond J. Safra Fellowship in Movement Disorders from The Michael J. Fox Foundation and employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. A.S. has nothing to report. M.G.P. reports the following: employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. D.M.A. reports the following: employment at the Jordan University of Science and Technology, Irbid, Jordan and a scholarship from Jordan University of Science and Technology. G.S. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada and fellowship training supported by the Parkinson's Foundation. A.E.L. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada. N.B. reports the following: consultancies with Centogene and Bridgebio; grants from the German Research Foundation (BR4328/2–2, GRK1957), Collaborative Center for X‐linked Dystonia‐Parkinsonism, and Else‐Kr{\"o}ner Fresenius‐Stiftung (HA17_2017); and employment at the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. V.T. reports the following: employment at University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. C.K. reports the following: consultancies with Centogene, honorarium for speaking from Desitin; grants from the German Research Foundation (SFB936 project C5 and FOR2488), and employment at theUniversity Medical Center Schleswig‐Holstein, Campus L{\"u}beck. K.L. reports the following: grants from the German Research Foundation, Damp Foundation, International Parkinson and Movement Disorder Society, and The Michael J. Fox Foundation (GP2 consortium) and employment at University of L{\"u}beck. M.J.N.B. reports the following: employment at California State University Sacramento, Sacramento, CA. C.B. reports the following: honoraria from Genzyme, Bayer, Novartis, and Teva; a grant from the German Research Foundation (FOR 2698); and employment at the Technical University Dresden, Dresden, Germany. A.M. reports the following: consultancies with Desitin, Merz Pharmaceuticals, and Admedicum; advisory boards of German Tourette Syndrome Association and Alliance of Patients With Chronic Rare Diseases; honoraria from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline, Desitin, Teva, and Takeda; grants from Possehl‐Stiftung (L{\"u}beck, Germany), Margot und J{\"u}rgen Wessel Stiftung (L{\"u}beck, Germany), Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), Cure Huntington Disease Initiative (CHDI), and Damp‐Stiftung (Kiel, Germany); academic research support from Deutsche Forschungsgemeinschaft Projects 1692/3–1, 4–1, SFB 936, and FOR 2698 (project numbers 396, 914, 663, 396, 577, 296, 396, 474, 989) and European Reference Network–Rare Neurological Diseases (Project 739510) employment at the University of L{\"u}beck and University Medical Center Schleswig‐Holstein, Campus L{\"u}beck; and royalties for the book (Oxford University Press). T.B. reports the following: advisory boards of Ipsen Pharma, Allergan, and Merz Pharmaceuticals; honoraria from Ipsen Pharma, Allergan, and Merz Pharmaceuticals; Grants, Research Group, DFG FOR 2698; and employment with the University Medical Center Schleswig‐Holstein, Campus L{\"u}beck. Neurogenetics Funding Information: This study was supported by the Else Kr{\"o}ner‐Fresenius Foundation (2018_A55) and the German Research Foundation (WE 5919/2‐1, SFB936 project C5, and FOR2488). Support by the European Reference Network–Rare Neurological Diseases (Project 739510) is also gratefully acknowledged. ",

year = "2021",

doi = "10.1002/mds.28679",

language = "English",

journal = "Movement Disorders",

issn = "0885-3185",

}

TY - JOUR

T1 - Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia

AU - Weissbach, Anne

AU - Steinmeier, Annika

AU - Pauly, Martje G.

AU - Al-Shorafat, Duha M.

AU - Saranza, Gerard

AU - Lang, Anthony E.

AU - Brüggemann, Norbert

AU - Tadic, Vera

AU - Klein, Christine

AU - Lohmann, Katja

AU - Brown, Matt J.N.

AU - Beste, Christian

AU - Münchau, Alexander

AU - Bäumer, Tobias

N1 - Funding Information: A.W. reports the following: Else Kröner‐Fresenius grant (EKFS, 2018_A55), German Research Foundation (DFG, WE5919/2–1), and Edmond J. Safra Fellowship in Movement Disorders from The Michael J. Fox Foundation and employment at the University Medical Center Schleswig‐Holstein, Campus Lübeck. A.S. has nothing to report. M.G.P. reports the following: employment at the University Medical Center Schleswig‐Holstein, Campus Lübeck. D.M.A. reports the following: employment at the Jordan University of Science and Technology, Irbid, Jordan and a scholarship from Jordan University of Science and Technology. G.S. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada and fellowship training supported by the Parkinson's Foundation. A.E.L. reports the following: employment at Toronto Western Hospital, Toronto, Ontario, Canada. N.B. reports the following: consultancies with Centogene and Bridgebio; grants from the German Research Foundation (BR4328/2–2, GRK1957), Collaborative Center for X‐linked Dystonia‐Parkinsonism, and Else‐Kröner Fresenius‐Stiftung (HA17_2017); and employment at the University Medical Center Schleswig‐Holstein, Campus Lübeck. V.T. reports the following: employment at University Medical Center Schleswig‐Holstein, Campus Lübeck. C.K. reports the following: consultancies with Centogene, honorarium for speaking from Desitin; grants from the German Research Foundation (SFB936 project C5 and FOR2488), and employment at theUniversity Medical Center Schleswig‐Holstein, Campus Lübeck. K.L. reports the following: grants from the German Research Foundation, Damp Foundation, International Parkinson and Movement Disorder Society, and The Michael J. Fox Foundation (GP2 consortium) and employment at University of Lübeck. M.J.N.B. reports the following: employment at California State University Sacramento, Sacramento, CA. C.B. reports the following: honoraria from Genzyme, Bayer, Novartis, and Teva; a grant from the German Research Foundation (FOR 2698); and employment at the Technical University Dresden, Dresden, Germany. A.M. reports the following: consultancies with Desitin, Merz Pharmaceuticals, and Admedicum; advisory boards of German Tourette Syndrome Association and Alliance of Patients With Chronic Rare Diseases; honoraria from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline, Desitin, Teva, and Takeda; grants from Possehl‐Stiftung (Lübeck, Germany), Margot und Jürgen Wessel Stiftung (Lübeck, Germany), Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), Cure Huntington Disease Initiative (CHDI), and Damp‐Stiftung (Kiel, Germany); academic research support from Deutsche Forschungsgemeinschaft Projects 1692/3–1, 4–1, SFB 936, and FOR 2698 (project numbers 396, 914, 663, 396, 577, 296, 396, 474, 989) and European Reference Network–Rare Neurological Diseases (Project 739510) employment at the University of Lübeck and University Medical Center Schleswig‐Holstein, Campus Lübeck; and royalties for the book (Oxford University Press). T.B. reports the following: advisory boards of Ipsen Pharma, Allergan, and Merz Pharmaceuticals; honoraria from Ipsen Pharma, Allergan, and Merz Pharmaceuticals; Grants, Research Group, DFG FOR 2698; and employment with the University Medical Center Schleswig‐Holstein, Campus Lübeck. Neurogenetics Funding Information: This study was supported by the Else Kröner‐Fresenius Foundation (2018_A55) and the German Research Foundation (WE 5919/2‐1, SFB936 project C5, and FOR2488). Support by the European Reference Network–Rare Neurological Diseases (Project 739510) is also gratefully acknowledged.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85107791988&partnerID=8YFLogxK

U2 - 10.1002/mds.28679

DO - 10.1002/mds.28679

M3 - Letters

AN - SCOPUS:85107791988

SN - 0885-3185

JO - Movement Disorders

JF - Movement Disorders

ER -

Multimodal Longitudinal Neurophysiological Investigations in Dopa-Responsive Dystonia

UN SDGs

Access to Document

Other files and links

Cite this